Literature DB >> 15486367

Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality.

Nadia N Hansel1, Barry Merriman, Edward F Haponik, Gregory B Diette.   

Abstract

STUDY
OBJECTIVES: Despite curative therapy, mortality remains high for hospitalized patients with tuberculosis (TB) in the United States. The purpose of this study was to describe the characteristics of hospitalized patients with TB and to identify patient characteristics associated with in-hospital mortality. DESIGN, SETTING, AND PATIENTS: Using the 2000 Nationwide Inpatient Sample, representing 20% of US hospital admissions, we identified 2,279 hospital admissions with a primary diagnosis of TB (International Classification of Diseases, ninth revision, codes, 010.xx to 018.xx). MEASUREMENTS AND
RESULTS: Mortality was the main outcome measure. Logistic regression analyses were performed including age, gender, race, insurance status, income, Deyo-adapted Charlson comorbidity index (DCI), HIV status, hospital admission source, and hospital characteristics as explanatory variables. A disproportionate number of patients hospitalized with TB were men (64%), nonwhite (72%), lived in areas with median incomes of < $35,000 (50%), and had publicly funded health insurance (49%) or no health insurance (17%). The mortality rate for patients hospitalized for TB was greater than that for non-TB hospital admissions (4.9% vs 2.4%, respectively; p < 0.001). Patients with TB who died during hospitalization were older (mean age, 65.1 vs 49.4 years, respectively; p < 0.001), had greater comorbid illness (DCI, 1.1 vs 0.55, respectively; p < 0.001), required longer hospitalizations (19.9 vs 13.9 days, respectively; p < 0.001), and accumulated substantially higher charges ($79,585 vs $31,610, respectively; p < 0.001) than did patients with TB who were alive at hospital discharge. In a multivariable analysis, older age, comorbid illnesses, and emergency department admissions were independently associated with mortality. The total charges for TB hospitalizations in the United States in 2000 exceeded $385 million.
CONCLUSIONS: Despite public health efforts, patients who are hospitalized with TB are frequently admitted through emergency care settings, have a high risk of in-hospital mortality, and incur substantial hospital charges. To improve TB health outcomes, more vigorous clinical management and prevention strategies should especially target older patients and those with comorbid medical conditions.

Entities:  

Mesh:

Year:  2004        PMID: 15486367     DOI: 10.1378/chest.126.4.1079

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

1.  The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection.

Authors:  Geoffrey Paul Kohn; Mehrdad Nikfarjam
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

2.  Trends in tuberculosis mortality in the United States, 1990-2006: a population-based case-control study.

Authors:  Richard S Jung; Jonathan R Bennion; Frank Sorvillo; Amy Bellomy
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

3.  Mortality in patients hospitalized for asthma exacerbations in the United States.

Authors:  Vidya Krishnan; Gregory B Diette; Cynthia S Rand; Andrew L Bilderback; Barry Merriman; Nadia N Hansel; Jerry A Krishnan
Journal:  Am J Respir Crit Care Med       Date:  2006-06-15       Impact factor: 21.405

4.  Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.

Authors:  K Owusu-Edusei; S M Marks; R Miramontes; E L Stockbridge; C A Winston
Journal:  Int J Tuberc Lung Dis       Date:  2017-04-01       Impact factor: 2.373

5.  Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.

Authors:  Suzanne F Beavers; Lisa Pascopella; Amy L Davidow; Joan M Mangan; Yael R Hirsch-Moverman; Jonathan E Golub; Henry M Blumberg; Risa M Webb; Rachel A Royce; Susan E Buskin; Michael K Leonard; Paul C Weinfurter; Robert W Belknap; Stephen E Hughes; Jon V Warkentin; Sharon F Welbel; Thaddeus L Miller; Saini R Kundipati; Michael Lauzardo; Pennan M Barry; Dolly J Katz; Denise O Garrett; Edward A Graviss; Jennifer M Flood
Journal:  Ann Am Thorac Soc       Date:  2018-06

6.  Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003.

Authors:  L T Nguyen; C D Hamilton; Q Xia; J E Stout
Journal:  Int J Tuberc Lung Dis       Date:  2011-02       Impact factor: 2.373

7.  In-hospital mortality of disseminated tuberculosis in patients infected with the human immunodeficiency virus.

Authors:  Rodrigo Pires dos Santos; Caroline Deutschendorf; Karin Scheid; Luciano Zubaran Goldani
Journal:  Clin Dev Immunol       Date:  2010-08-04

8.  Economics of United States tuberculosis airline contact investigation policies: a return on investment analysis.

Authors:  Margaret S Coleman; Karen J Marienau; Nina Marano; Suzanne M Marks; Martin S Cetron
Journal:  Travel Med Infect Dis       Date:  2013-11-08       Impact factor: 6.211

Review 9.  Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States.

Authors:  Amit S Chitnis; Ramsey Cheung; Robert G Gish; Robert J Wong
Journal:  J Immigr Minor Health       Date:  2021-06-23

10.  Deaths among tuberculosis cases in Shanghai, China: who is at risk?

Authors:  Xin Shen; Kathryn Deriemer; Zheng'an Yuan; Mei Shen; Zhen Xia; Xiaohong Gui; Lili Wang; Jian Mei
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.